AI assistant
Sending…
Dare Bioscience, Inc. — Director's Dealing 2018
Apr 12, 2018
34825_dirs_2018-04-11_862e24a1-038a-418d-aa84-e44249eea417.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2018-04-09
Reporting Person: Grossman Jessica D. (Director)
More from Dare Bioscience, Inc.
Proxy Solicitation & Information Statement
2026
Jun 1
Proxy Solicitation & Information Statement
2026
Jun 1
Capital/Financing Update
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Apr 22
Board/Management Information
2026
Apr 17
Capital/Financing Update
2026
Apr 13